期刊文献+

不同HPLC测定方法测定氨磷汀及其相关物质的比较 被引量:1

Detection of Amifostine and Its Related Substance with Different HPLC Method
在线阅读 下载PDF
导出
摘要 目的比较中国卫生部及美国药典(USP35)颁布的氨磷汀及其相关物质的高效液相(HPLC)测定方法。方法美国药典USP35测定方法采用C8色谱柱,流动相采用7∶18(甲醇∶0.94g/L己烷磺酸)溶液,检测波长为220nm,流速1.0m L/min;中国卫生部的标准采用C18色谱柱,流动相采用1∶1(甲醇∶3.5mmol/L辛烷磺酸钠)溶液,检测波长均为220nm,流速0.7 m L/min。结果两种方法检测氨磷汀及相关物质都符合对杂质的要求。结论美国药典USP35的检测方法对氨磷汀及相关物质检测的质量控制更好。 Objective To compare the HPLC measurement method for analysis amifostine,which validated by China Ministry of Public Health and United States Pharmacopeia( USP 35). Methods The HPLC methods for determination of amifostine,validated by USP 35 and China Ministry of Public Health Department were comparatively described. Amifostine and its related substances were determined with the mobile phase of 7∶ 18( methanol∶ 0. 94 g /L hexanesulfonic acid sodium solution),with flow rate of 1. 0m L/min and 1∶ 1( methanol∶3. 5mmol / L octanesulfonic acid sodium solution,with flow rate of 0. 7m L / min,respectively. Wave length of the two standards’ detection was 220 nm. Results Both of the two standards were meet analysis requirement of amifostine and its related substances. Conclusion USP35 is better for the quality control of amifostine.
出处 《标记免疫分析与临床》 CAS 2015年第2期142-144,共3页 Labeled Immunoassays and Clinical Medicine
关键词 高效液相 氨磷汀 美国药典 HPLC Amifostine USP
  • 相关文献

参考文献9

二级参考文献40

  • 1张建民.679例丙戊酸血药浓度监测后的药学服务[J].中国药房,2011,22(14):1338-1340. 被引量:3
  • 2焦正,赵志刚,施孝金,钟明康.比较HPLC和FPIA法测定人血清中卡马西平的血药浓度[J].中国临床药理学杂志,2004,20(4):291-294. 被引量:17
  • 3陈暑波,田野,陆雪官.放射防护剂氨磷汀的临床应用[J].国外医学(临床放射学分册),2004,27(6):404-407. 被引量:3
  • 4国家药典编委会.中华人民共和国药典[M].北京:中国医药科技出版社,2010:38,111.
  • 5李镒冲,李晓松.两种测量方法定量测量结果的一致性评价[J].现代预防医学,2007,34(17):3263-3266. 被引量:159
  • 6Kouvaris JR. Kouloulias VE, Vlahos LJ. Amifostine: TheFirst Selcctive-Target and Broad-Spectrum Radioprotector[J]. The2007,12(6) :738 - 747.
  • 7Bai F- Kirstein MN,Hanna SK, et al. New liquidchromatographic assay with electrochemical detection forthe measurement of amifostine and WR1065 [J]. JChromatogr B Analyt Technol Biomed Life Sci. 2002 ,772?2):257 - 265.
  • 8Bolner A, Barbato L, Tagliaro P', et al. Determination ofapomorphine in human plasma by ?ilumina extraction andhigh-performance liquid chromatography withelectrochemical detection [J]. Forejisic Sci Int,1997,89( 1-2):81 -01.
  • 9British Pharmacopoeia Commission. British Phmarmeopoeia[M]. Published by The Stationery Office, 2011, VollI : 1912-1914.
  • 10Deubel A, Holzgrabe V. Development of an enhanced separation of erythromycin and its related substances byliquid chromatography[J]. J Pharmaceut Biomed, 2007, 43: 493-498.

共引文献23

同被引文献11

  • 1中国药典2010年版.二部[S].2010:附录29.
  • 2KOUVARIS JR, KOULOULIAS VE, VLAHOS LJ. Amifostine: the first selective-target and broad-spectrum radioprotector [ J 1. Oncologist, 2007, 12 ( 6 ): 738.
  • 3YBH00012009国家药品标准[S],2009.
  • 4USP 38-NF 33 [S]. 2015:2165.
  • 5KORST AEC, BOVEN E, van der STERRE MLT, et al. Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of earboplatin in mice [ J]. British J Cancer, 1997,75 ( 10 ): 1439.
  • 6JAHNUKAINEN K, JAHNUKAINEN T, SALMI TT, et al. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats[ J ]. Cancer Res. , 2001,61 ( 17 ): 6423.
  • 7van der WILT CL, van LAAR JA, GYERGYA'Y F, et al. Biochemical modification of the toxicity and the anti-turnout effect of 5-fluorouracil and cis-platinum by WR-2721 in mice [ J ]. Eur J Cancer, 1992, 28A ( 12 ): 2017.
  • 8GLOVER D, NEGENDANK W, DELIVORIA-PAPADOPOULOS M, et al. Alterations in oxygen transport following WR-2721 [ J ]. Int J Radiat Oncol Biol Phys, 1984, 10( 9 ): 1565.
  • 9KOUKOURAKIS MI, GIATROMANOLAKI A, CHONG W, et al. Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha [ J]. Cancer Chemother Pharmacol, 2004, 53 ( 1 ): 8.
  • 10PANDIT JJ, ALLEN C, LITTLE E, et al. Does amifostine reduce metabolic rate?Effect of the drug on gas exchange and acute ventilatory hypoxic response in humans [ J ]. Pharmaceuticals ( Basel ), 2015,8 ( 2 ): 186.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部